TORONTO, ON/ ACCESSWIRE/ January 12, 2023/ AI/ML Innovations Inc. (“AI/ML” or the “Company”) (CSE: AIML); (OTCQB: AIMLF);(FWB:42 FB) is happy to reveal the closing of its formerly revealed (December 16, 2022) warrant workout reward program (the “Program”) meant to motivate the workout of as much as 5,648,000 unlisted typical share purchase warrants of the Company (the “Eligible Warrants”) exercisable for one typical share of the Company (each a “Common Share”) at a cost of $0.075 per Common Share. Qualified Warrants that stay unexercised following the conclusion of this early workout program continue to be exercisable for Common Shares on the initial terms as they existed prior to the Program. Pursuant to the Program, the holders worked out 2,420,000 Eligible Warrants for earnings of $181,500 which will be utilized for basic working capital. Taking part holders were released 2,420,000 extra typical share purchase warrant (an “Incentive Warrant”). Each Incentive Warrant entitles the holder to buy one extra Common Share till 5:00 p.m. (Vancouver time) on January 9, 2024 at a cost of $0.10 per Common Share. The Incentive Warrants and any Common Shares issuable on the workout thereof will go through a four-month hold duration from the date of issuance of the Incentive Warrants pursuant to appropriate Canadian securities laws. For more details, please contact: Blake Fallis (778) 405-0882 or [email protected]
For in-depth info please see the Company’s site at https://aiml-innovations.com/ or the Company’s submitted files at www.sedar.com. About AI/ML Innovations Inc. AI/ML Innovations Inc. has actually straightened its service operations to profit from the growing fields of expert system (AI) and artificial intelligence (ML), with a preliminary financial investment concentrate on emerging digital health and wellness business that take advantage of AI, ML, cloud computing and digital platforms to drive transformative health care management options and accuracy assistance shipment throughout the health continuum. Through tactical collaborations with Health Gauge (70% owned by AIML), Tech2Heal (as much as 22% ownership rights, with 9.44% presently owned), AI Rx Inc. (70% owned by AIML) and other prepared accretive financial investments, the Company continues to profit from broadening development locations, to the advantage of all the Company’s stakeholders. The Company’s shares are traded on the Canadian Securities Exchange under the sign “AIML”, the OTCQB Venture Market under “AIMLF”, and the Frankfurt Stock Exchange under “42FB”. Neither the CSE nor its Regulation Services Provider (as that term is specified in the policies of the CSE) accepts duty for the adequacy or precision of this release. Specific declarations in this press release are “positive declarations”, which show management’s expectations concerning the timing of the filing of the Required Documents. All declarations aside from declarations of historic reality consisted of in this press release are forward looking declarations. Such positive declarations include dangers and unpredictabilities, as they show management’s present beliefs and are based upon details presently offered to management. Real outcomes might vary materially from those prepared for in the declarations made. The positive declarations are specifically certified in their whole by this cautionary declaration. The positive declarations are made since the date of this press release and AI/ML presumes no responsibility to upgrade or modify them to show brand-new occasions or situations other than as specifically needed by suitable securities law. More info concerning the unpredictabilities and threats can be discovered in the disclosure files submitted by AI/ML with the securities regulative authorities, offered at www.sedar.com. SOURCE: AI/ML Innovations Inc.
AI/ML Innovations Inc. Reveals Successful Closing of the Warrant Repricing and Early Warrant Exercise Incentive Program
Byindianadmin
Jan 13, 2023